Chronic rhinosinusitis with nasal polyps (CRSwNP) - Mepolizumab convinces in real-world studies

被引:0
|
作者
von Weikersthal, Gabi Fischer
机构
关键词
D O I
10.1055/a-2280-9363
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
[No abstract available]
引用
收藏
页码:551 / 551
页数:1
相关论文
共 50 条
  • [41] Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study
    Jared Silver
    Elizabeth Packnett
    Julie Park
    Arijita Deb
    Allergy, Asthma & Clinical Immunology, 19
  • [42] Knowledge gaps in using type 2 biologics for real-world treatment of chronic rhinosinusitis with nasal polyps
    Lou, Hongfei
    Zhang, Luo
    ALLERGY, 2022, 77 (07) : 1952 - 1954
  • [43] Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP): Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, and mepolizumab
    Klimek L.
    Förster-Ruhrmann U.
    Beule A.G.
    Chaker A.M.
    Hagemann J.
    Klimek F.
    Casper I.
    Huppertz T.
    Hoffmann T.K.
    Dazert S.
    Deitmer T.
    Olze H.
    Strieth S.
    Wrede H.
    Schlenter W.
    Welkoborsky H.-J.
    Wollenberg B.
    Bergmann C.
    Cuevas M.
    Beutner C.
    Gröger M.
    Becker S.
    Allergo Journal International, 2022, 31 (6) : 149 - 160
  • [44] Letter to the Editor Regarding "Real-world Predictors of Dupilumab Prescription in Patients With Chronic Rhinosinusitis With Nasal Polyps"
    Liu, Yiheng
    Dai, Weiran
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2025,
  • [45] Successful Treatment of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Tezepelumab: A Case Report
    Cristallo, Mattia
    Filieri, Mirco
    Spataro, Federico
    Muolo, Loredana
    Nettis, Eustachio
    Di Girolamo, Attilio
    IMMUNOLOGY, 2025,
  • [46] Biologic use and treatment patterns in patients with chronic rhinosinusitis with nasal polyps: a US real-world study
    Silver, Jared
    Packnett, Elizabeth
    Park, Julie
    Deb, Arijita
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [47] Real-World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
    Dorling, Marisa
    Hernaiz-Leonardo, Juan C.
    Pascual, Athenea
    Janjua, Arif
    Thamboo, Andrew
    Javer, Amin
    LARYNGOSCOPE, 2024, 134 (07): : 3054 - 3059
  • [48] Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
    Rovina, Nikoletta
    Tsami, Mairi
    Panagiotou, Marios
    Syrigou, Ekaterini
    Koulouris, Nikolaos
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [49] Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
    Galletti, Cosimo
    Ciodaro, Francesco
    Barbieri, Maria Antonietta
    Gambino, Fabiana
    Ferrisi, Maria Grazia
    Portelli, Daniele
    Catalano, Natalia
    Spina, Edoardo
    Freni, Francesco
    Galletti, Bruno
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2024, 45 (04)
  • [50] Mepolizumab Reduces Systemic Corticosteroid Use in Patients with Chronic Rhinosinusitis with Nasal Polyps
    Chupp, G. L.
    Alobid, I
    Lugogo, N.
    Kariyawasam, H. H.
    Bourdin, A.
    Chaker, A. M.
    Sousa, A. R.
    Martin, N.
    Yang, S.
    Mayer, B.
    Chan, R.
    Matucci, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)